Shares in Novo Nordisk fell more than 4% as its CEO laid out plans to launch new blockbuster drugs in the next few years while expanding into further treatment areas.
Source link
About The Author
Wegovy Maker Novo Nordisk Targets Several New Blockbuster Drugs in Coming Years